Kaplan N M
Arch Intern Med. 1975 May;135(5):660-3. doi: 10.1001/archinte.135.5.660.
The rise in plasma renin activity (PRA) that accompanies thiazide diuretic therapy of hypertension may interfere with therapeutic effectiveness and contribute to hypokalemia. In an attempt to provide a basis for the previously empiric use of antihypertensive drugs, 20 hypertensive subjects were given a diuretic alone for three weeks and a diuretic plus methylodopa, which lowers PRA, for three weeks. The thiazide-induced rise in PRA was blunted by the methyldopa, while bl-od pressure fell even more and renal function was well maintained. The combination of a renin-lowering drug and a diuretic is rational and effective therapy for hypertension.
噻嗪类利尿剂治疗高血压时伴随的血浆肾素活性(PRA)升高可能会干扰治疗效果并导致低钾血症。为了给之前经验性使用抗高血压药物提供依据,20名高血压患者先单独服用利尿剂3周,然后服用利尿剂加能降低PRA的甲基多巴3周。甲基多巴抑制了噻嗪类药物引起的PRA升高,同时血压下降得更多,且肾功能维持良好。联合使用降低肾素的药物和利尿剂是治疗高血压的合理且有效的方法。